Basit öğe kaydını göster

dc.contributor.authorAlemdaroglu, Songul
dc.contributor.authorDurdag, Gulsen Dogan
dc.contributor.authorBaran, Safak Yilmaz
dc.contributor.authorSimsek, Seda Yuksel
dc.contributor.authorYetkinel, Selcuk
dc.contributor.authorYaginc, Didem Alkas
dc.contributor.authorGuler, Ozan Cem
dc.contributor.authorCelik, Husnu
dc.date.accessioned2022-08-17T12:12:43Z
dc.date.available2022-08-17T12:12:43Z
dc.date.issued2021
dc.identifier.issn2148-4902en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430360/pdf/NCI-8-345.pdf
dc.identifier.urihttp://hdl.handle.net/11727/7379
dc.description.abstractOBJECTIVE: The objective of the study was to investigate the prognostic factors of the elderly group and their effects on survival by examining the histopathological features, surgical treatment protocols, and treatment modalities of patients diagnosed with endometrial cancer (EC). METHODS: The records of 397 EC patients who completed their treatment and follow-up at a single center between 2012 and 2019 were evaluated retrospectively. The patients were evaluated in two groups as <70 years old (n: 301; 75.8%) and >70 years old (n: 96; 24.2%). Following the evaluation of histopathological features and treatment protocols, independent risk factors influencing survival were investigated with the Cox regression model. RESULTS: The incidence of non-endometrioid histology (16.3% vs. 32.3%, p: 0.001), high-grade tumors (50.5% vs. 69.8%; p: 0.001), and >50 myometrial invasion (19.6% vs. 36.5%, p: 0.003) in the >70 age group was more frequent than that in the <70 age group. The independent risk factors on overall survival in the >70 age group were determined as non-endometrioid histology (HR: 5.9; 95% CI: 1.4- 24.7) and lymph node metastasis (HR: 6.4; 95% CI: 1.6-25.0). In the <70 age group, non-endometrioid histology (HR: 11.3; 95% CI: 4.0-32.0) was identified as the only independent risk factor affecting 5-year survival. CONCLUSION: EC, with non-endometrioid histology, which is observed at a higher rate in elderly patients despite equal surgery and adjuvant therapy, is the primary factor that affects survival.en_US
dc.language.isoengen_US
dc.relation.isversionof10.14744/nci.2020.47154en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectElderlyen_US
dc.subjectendometrial canceren_US
dc.subjectnon-endometrioiden_US
dc.subjectprognosisen_US
dc.titlePrognostic factors of endometrial cancer in elderly patient group and their effects on survivalen_US
dc.typearticleen_US
dc.relation.journalNORTHERN CLINICS OF ISTANBULen_US
dc.identifier.volume8en_US
dc.identifier.issue4en_US
dc.identifier.startpage345en_US
dc.identifier.endpage353en_US
dc.identifier.wos000693118100005en_US
dc.contributor.pubmedID34585068en_US
dc.contributor.orcID0000-0003-4335-6659en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.contributor.researcherIDAAI-8400-2021en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster